Related Experiment Video
Updated: Feb 2, 2026

The Dimethylnitrosamine Induced Liver Fibrosis Model in the Rat
Published on: June 17, 2016
Fibroblast activation protein in liver fibrosis
Angelina J Lay1, Hui Emma Zhang1, Geoffrey William McCaughan1
1Centenary Institute, Locked Bag No.6, Newtown, NSW, Australia.
Abstract:
Fibroblast activation protein (FAP) belongs to the dipeptidyl peptidase IV (DPP4; CD26) gene family. Other related genes in this family of enzyme include DPP4, 8 and 9. The FAP serine protease has the rare property of both dipeptidyl peptidase and endopeptidase activities capable of cleaving the post-proline bond at two or more residues from the N-terminus. FAP is involved in a variety of biological processes but its expression in healthy tissues is low. In contrast, FAP is significantly elevated in pathological conditions such as at sites of tissue remodelling and repair. Its differential pattern of expression in diseases supports the emerging concept for FAP as a potential disease biomarker as well as a useful therapeutic target for drug intervention. This review summarizes the current knowledge of FAP, particularly its diagnostic and pathological significance in liver fibrosis.
Related Concept Videos
Activation and Inactivation of G Proteins
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Introduction to Fibroblasts
Cystic Fibrosis: Management
Sinus disease and chronic...
Protein Digestion
Liver Histology
Hepatocytes perform a variety of essential functions. They secrete...

